Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts
1 other identifier
interventional
10,000
1 country
1
Brief Summary
Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2012
CompletedFirst Posted
Study publicly available on registry
May 15, 2012
CompletedStudy Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedNovember 16, 2012
November 1, 2012
3 months
May 11, 2012
November 15, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of prophylaxis against venous thromboembolism
patients with prophylaxis/total patients
3 months
Secondary Outcomes (2)
ordering time after admission or transfer of a patient
3 months
acceptance of the eAlerts
3 months
Study Arms (1)
roll out of eAlerts
EXPERIMENTALRoll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Interventions
An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Eligibility Criteria
You may qualify if:
- all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
- staying at least 24 h in a ward
You may not qualify if:
- outpatients,
- ward without CPOE,
- patients transferred from an intervention to a control ward and vice versa
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Zurich, Center for Clinical Research
Zurich, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juerg Blaser, Prof. PhD
University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2012
First Posted
May 15, 2012
Study Start
June 1, 2012
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
November 16, 2012
Record last verified: 2012-11